ELISA TNFSF14 anti-

Quantity :100µL Clone Number: Aliases:CD 258 antibody; CD258 antibody; CD258 antigen antibody; Delta transmembrane LIGHT antibody; Herpes virus entry mediator ligand antibody; Herpesvirus entry mediator A antibody; Herpesvirus entry mediator ligand antibody; herpesvirus entry mediator-ligand antibody; HVEM L antibody; HVEM-L antibody; HVEmL antibody; Ligand for herpesvirus entry mediator antibody; LIGHT antibody; LTg antibody; soluble form antibody; TNF14 antibody; TNF14_ antibody; TNFSF 14 antibody; Tnfsf14 antibody; TNFSF14 protein antibody; TR 2 antibody; TR2 antibody; Tumor necrosis factor (ligand) superfamily; member 14 antibody; Tumor necrosis factor ligand superfamily member 14 antibody; Tumor necrosis factor ligand superfamily; member 14 antibody; Tumor necrosis factor receptor like 2 antibody; tumor necrosis factor receptor-like 2 antibody; Tumor necrosis factor superfamily member 14 antibody; Tumor necrosis factor superfamily member LIGHT antibody Product Type:Polyclonal Antibody Immunogen Species:Homo sapiens () UniProt ID:O43557 Immunogen:SyntheQuantityd peptide derived from internal of TNF14. Raised in:Rabbit Reactivity: Tested Applications:ELISA, IF; IF:1:100-1:500 Background:Cytokine that binds to TNFRSF3/LTBR. Binding to the decoy receptor TNFRSF6B modµLates its effects. Activates NFKB, stimµLates the proliferation of T-cells, and inhibits growth of the adenocarcinoma HT-29. Acts as a receptor for Herpes simplex virus. Mauri D.N., Immunity 8:21-30(1998). Harrop J.A., J. Biol. Chem. 273:27548-27556(1998). Granger S.W., J. Immunol. 167:5122-5128(2001). Clonality:Polyclonal Isotype:IgG Purification Method:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. Conjµgate:Non-conjµgated Buffer:Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Form:liquid Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names:TNFSF14 Research Areas:Immunology